Program overview
Context
Indication: Prostatic Neoplasms
Mechanism: Unknown
Modality: Unknown
Sponsor: Centre Antoine Lacassagne
Registry Stop Signal
METFORMIN
METFORMIN is flagged as registry stop signal because public records show a registry stop signal, public results not found after completion. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Scores
Risk-signal summary
Registry: 5/5
Timeline: 1/5
Recruitment burden: 1/5
Results availability: 3/5
Program risk: 5/5
Evidence
Public links
https://clinicaltrials.gov/study/NCT01796028 | https://clinicaltrials.gov/study/NCT01215032
Linked trials
Trial-level signal details
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT01796028 | Low Signal (COMPLETED) | stale_update_signal | Completed No Results Found Signal | rare_population_signal |
| NCT01215032 | Registry Stop Signal (TERMINATED) | stale_update_signal | Low Signal | None |